SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Abolhassani H) "

Sökning: WFRF:(Abolhassani H)

  • Resultat 61-70 av 304
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
61.
  •  
62.
  •  
63.
  •  
64.
  •  
65.
  •  
66.
  • Matuozzo, D, et al. (författare)
  • Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
  • 2022
  • Ingår i: medRxiv : the preprint server for health sciences. - : Cold Spring Harbor Laboratory.
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • BackgroundWe previously reported inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity in 1-5% of unvaccinated patients with life-threatening COVID-19, and auto-antibodies against type I IFN in another 15-20% of cases.MethodsWe report here a genome-wide rare variant burden association analysis in 3,269 unvaccinated patients with life-threatening COVID-19 (1,301 previously reported and 1,968 new patients), and 1,373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. A quarter of the patients tested had antibodies against type I IFN (234 of 928) and were excluded from the analysis.ResultsNo gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants wasTLR7, with an OR of 27.68 (95%CI:1.5-528.7,P=1.1×10−4), in analyses restricted to biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR=3.70 [95%CI:1.3-8.2],P=2.1×10−4). Adding the recently reportedTYK2COVID-19 locus strengthened this enrichment, particularly under a recessive model (OR=19.65 [95%CI:2.1-2635.4];P=3.4×10−3). When these 14 loci andTLR7were considered, all individuals hemizygous (n=20) or homozygous (n=5) for pLOF or bLOF variants were patients (OR=39.19 [95%CI:5.2-5037.0],P=4.7×10−7), who also showed an enrichment in heterozygous variants (OR=2.36 [95%CI:1.0-5.9],P=0.02). Finally, the patients with pLOF or bLOF variants at these 15 loci were significantly younger (mean age [SD]=43.3 [20.3] years) than the other patients (56.0 [17.3] years;P=1.68×10−5).ConclusionsRare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old.
  •  
67.
  •  
68.
  •  
69.
  •  
70.
  • Nguyen, T, et al. (författare)
  • Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kδ syndrome 2
  • 2023
  • Ingår i: The Journal of experimental medicine. - : Rockefeller University Press. - 1540-9538 .- 0022-1007. ; 220:6
  • Tidskriftsartikel (refereegranskat)abstract
    • Heterozygous loss-of-function (LOF) mutations in PIK3R1 (encoding phosphatidylinositol 3-kinase [PI3K] regulatory subunits) cause activated PI3Kδ syndrome 2 (APDS2), which has a similar clinical profile to APDS1, caused by heterozygous gain-of-function (GOF) mutations in PIK3CD (encoding the PI3K p110δ catalytic subunit). While several studies have established how PIK3CD GOF leads to immune dysregulation, less is known about how PIK3R1 LOF mutations alter cellular function. By studying a novel CRISPR/Cas9 mouse model and patients’ immune cells, we determined how PIK3R1 LOF alters cellular function. We observed some overlap in cellular defects in APDS1 and APDS2, including decreased intrinsic B cell class switching and defective Tfh cell function. However, we also identified unique APDS2 phenotypes including defective expansion and affinity maturation of Pik3r1 LOF B cells following immunization, and decreased survival of Pik3r1 LOF pups. Further, we observed clear differences in the way Pik3r1 LOF and Pik3cd GOF altered signaling. Together these results demonstrate crucial differences between these two genetic etiologies.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 61-70 av 304
Typ av publikation
tidskriftsartikel (276)
konferensbidrag (23)
forskningsöversikt (5)
Typ av innehåll
refereegranskat (263)
övrigt vetenskapligt/konstnärligt (41)
Författare/redaktör
Abolhassani, H (300)
Aghamohammadi, A (165)
Rezaei, N (131)
Yazdani, R (109)
Azizi, G (97)
Hammarstrom, L (57)
visa fler...
Delavari, S (39)
Arabloo, J (38)
Fischer, F (37)
Monasta, L (34)
Rawaf, S (34)
Mohammed, S (33)
Mokdad, AH (33)
Mestrovic, T (32)
Chavoshzadeh, Z (32)
Kisa, A (31)
Yonemoto, N (31)
Hosseinzadeh, M (30)
La Vecchia, C (30)
Sahebkar, A (30)
Shaikh, MA (30)
Murray, CJL (30)
Alvis-Guzman, N (29)
Mohammadian-Hafsheja ... (29)
Oancea, B (28)
Singh, JA (28)
Waheed, Y (28)
Tavakol, M (28)
Mahdaviani, SA (28)
Ancuceanu, R (27)
Ghashghaee, A (27)
Hay, SI (27)
Kisa, S (27)
Koyanagi, A (27)
Naghavi, M (27)
Olagunju, AT (27)
Saddik, B (27)
Samy, AM (27)
Sathian, B (27)
Chattu, VK (26)
Dandona, L (26)
Dandona, R (26)
Diaz, D (26)
Kabir, A (26)
Krishan, K (26)
Lasrado, S (26)
Majeed, A (26)
Sabour, S (26)
Parvaneh, N (26)
Jamee, M (26)
visa färre...
Lärosäte
Karolinska Institutet (301)
Uppsala universitet (18)
Göteborgs universitet (16)
Högskolan Dalarna (11)
Umeå universitet (1)
Kungliga Tekniska Högskolan (1)
visa fler...
Linköpings universitet (1)
Jönköping University (1)
Lunds universitet (1)
Mittuniversitetet (1)
visa färre...
Språk
Engelska (304)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (32)
Naturvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy